September 9, 2024-September 11, 2024 Register Now for C-Path’s Premier Global Impact Conference We are thrilled to invite you to the inaugural Critical Path Institute Global Impact Conference taking place this September...
C-Path’s Role in IHI Call 4: Enhancing Rare Disease Clinical Trials This memo outlines how C-Path can contribute as a key strategic regulatory partner to the Innovative Health Initiative’s (I
December 1, 2022 C-Path and Ultragenyx Announce Data Sharing Agreement to Support Rare Disease Treatment and Novel Therapies TUCSON, Ariz., Dec. 1, 2022 — Critical Path Institute (C-Path) and Ultragenyx Pharmaceutical, Inc., (NASDAQ: RARE), a biopharmac
